-
Haemonetics Guides FY 2012 EPS $3.50-$3.62 vs. $3.56 Estimate (HAE)
Monday, May 2, 2011 - 8:08am | 17Haemonetics (NYSE: HAE) Guides FY 2012 EPS $3.50-$3.62 vs. $3.56 Estimate
-
Haemonetics Reports it Will Buy Back Up to $50M of Stock (HAE)
Monday, May 2, 2011 - 8:07am | 21Haemonetics (NYSE: HAE) Reports it Will Buy Back Up to $50M of Stock
-
Haemonetics Reports EPS of $0.85 vs. $0.83 Estimate; Revenues $170M vs. $180.31M Estimate (HAE)
Monday, May 2, 2011 - 8:02am | 21Haemonetics (NYSE: HAE) Reports EPS of $0.85 vs. $0.83 Estimate; Revenues $170M vs. $180.31M Estimate
-
Jefferies Raises PT On West Pharmaceutical To $45
Friday, April 29, 2011 - 7:05am | 25Jefferies & Company has raised the price target on West Pharmaceutical (NYSE: WST) and maintains its Hold rating.
-
Span-America Increases Quarterly Cash Dividend by 10% To $0.11
Friday, April 29, 2011 - 6:58am | 40Span-America Medical Systems (NASDAQ: SPAN) announced today that the Board of Directors increased the quarterly cash dividend by 10% to $0.11 per share. The dividend is payable June 3, 2011, to shareholders of record on May 18, 2011.
-
West Pharma Guides 2011 EPS $2.21-$2.42 (WST)
Thursday, April 28, 2011 - 9:16am | 15West Pharma (NYSE: WST) Guides 2011 EPS $2.21-$2.42
-
Top five companies Stocks in the Specialty Chemicals industry- ROC, NLC, CYT, FOE, ECL
Thursday, April 28, 2011 - 9:14am | 12001) Rockwood Holdings (NYSE:ROC) ranks first with a gain of 10.09%- The company reported net income of $178 million, or $2.24 a share, for the three months ended March 31. That compares with net income of $36.9 million, or 48 cents a share, in the same quarter last year. The results included a $...
-
Dentsply International Reports EPS of $0.49 vs. $0.48 Estimate; Revenues $570.5M vs. $555.7M Estimate (XRAY)
Thursday, April 28, 2011 - 8:47am | 22Dentsply International (NASDAQ: XRAY) Reports EPS of $0.49 vs. $0.48 Estimate; Revenues $570.5M vs. $555.7M Estimate
-
West Pharma Services Reports EPS of $0.60 vs. $0.62 Estimate; Revenues $295.4M vs. $291.97M Estimate
Thursday, April 28, 2011 - 7:23am | 23West Pharma Services (NYSE: WST) Reports EPS of $0.60 vs. $0.62 Estimate; Revenues $295.4M vs. $291.97M Estimate
-
Endologix Guides FY 2011 Revenue $78M-$82M (ELGX)
Thursday, April 21, 2011 - 4:10pm | 16Endologix Guides FY 2011 Revenue $78M-$82M (NASDAQ: ELGX)
-
Merit Medical Announces 5-for-4 Forward Stock Split (MMSI)
Thursday, April 21, 2011 - 9:31am | 55Merit Medical Systems (NASDAQ: MMSI) today announced that its Board of Directors has approved a five-for-four forward stock split of the Company's Common Stock, to be effected in the form of a stock dividend of one share of the Company's Common Stock for every four shares outstanding.
-
Align Technology Reports EPS $0.04 vs. $0.17 Estimate; Revenues $104.9M vs. $100.63M Estimate (ALGN)
Wednesday, April 20, 2011 - 4:04pm | 21Align Technology (NASDAQ: ALGN) Reports EPS $0.04 vs. $0.17 Estimate; Revenues $104.9M vs. $100.63M Estimate
-
Cerus Appoints William Greenman as President and CEO
Wednesday, April 20, 2011 - 8:36am | 75The Board of Directors of Cerus Corporation (NASDAQ: CERS) announced today that William “Obi” Greenman has been appointed president and chief executive officer, and a director on Cerus' Board, effective immediately. Mr. Greenman succeeds Claes Glassell, who has resigned as president and chief...
-
Wedbush Comments On "Solid" VASC Quarter
Wednesday, April 20, 2011 - 8:00am | 123Wedbush is commenting on Vascular Solutions Inc.'s (NASDAQ: VASC) Q1, which it is calling a “solid quarter.” “Vascular Solutions reported Q1 results that were right on target with expectations,” Wedbush writes. “At a time when most of the medical device industry is experiencing a major downturn in...
-
Vascular Solutions Guides Q2 EPS $0.11-$0.13; Revenue $22.3M-$22.7M (VASC)
Tuesday, April 19, 2011 - 4:11pm | 19Vascular Solutions (NASDAQ: VASC) Guides Q2 EPS $0.11-$0.13; Revenue $22.3M-$22.7M